ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Theranostics. 2020 Jan 16;10(5):2342-2357. doi: 10.7150/thno.40395. eCollection 2020.
Theranostics. 2020.
PMID: 32104507
Free PMC article.